A Q&A With Parrish Galliher About Adopting Single-Use Systems
August 7, 2014 - Process Development Forum
This week, Process Development Forum speaks with Parrish Galliher, Chief Technology Officer Upstream at Cytiva, about trends within the bioprocess area
…
Defining Critical Quality Attributes for Monoclonal Antibody Ther
July 18, 2014 - By: Anurag S. Rathore, PhD, Andrew Weiskopf, Andrew J. Reason , BioPharm International
An approach for establishing the CQAs of a mAb product by evaluating impact and uncertainty during risk assessment.
…
FDA Urged to Preserve Biosimilar Naming Conventions
July 17, 2014 - BioPharm International
The Generic Pharmaceutical Association (GPhA) is reporting that 32 organizations, including pharmacies and labor unions, have signed a
…
Analyzing Proteins Using SEC, MALS, and UHPLC
July 17, 2014 - Cynthia Challener, PhD BioPharm International
Light scattering analysis combined with more rapid size exclusion chromatography improves protein characterization.
…
Q&A with Eric Langer, about the evolution of the role of CMO’s
July 7, 2014 - Process Development Forum
This week Process Development Forum speaks with Eric Langer, President and Managing Partner at BioPlan Associates, and the author of a number of biopharma s
…
Concentrating Feed—an Applicable Approach to Improve Antibody P
June 29, 2014 - By: Ping Xu, Xiao-Ping Dai, Albert Kao, Rosario Scott, Reb Russell BioPharm International
In this study, the authors evaluated different approaches to prepare highly concentrated feed media for fed-batch Chinese hamster ovary cell culture. By rais
…
Global Expansion Shapes Drug Oversight
June 16, 2014 - By: Jill Wechsler BioPharm International
Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.
Gowning Practices Provide Clues to cGMP Compliance
June 13, 2014 - By: Eric Bohn Pharmaceutical Technology
R
eview gowning p
Bureaucratic Roadblocks Threaten Biopharma Growth
There is a clear link b
June 13, 2014 - By: Jim Greenwood BioPharm International
Protecting intellectual property rights is vital to biopharmaceutical innovation.
Challenges in Analytical Method Development and Validation
June 13, 2014 - By: Susan Haigney BioPharm International
